WallStreetZenWallStreetZen

NASDAQ: RMTI
Rockwell Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their RMTI stock forecasts and price targets.

Forecast return on equity

Is RMTI forecast to generate an efficient return?

Company
-10.19%
Industry
20.83%
Market
-21.96%
RMTI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RMTI forecast to generate an efficient return on assets?

Company
-5.89%
Industry
10.11%
RMTI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RMTI earnings per share forecast

What is RMTI's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.17
Avg 2 year Forecast
-$0.09

RMTI revenue forecast

What is RMTI's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$69.9M-20.53%
Avg 2 year Forecast
$81.6M-7.25%
RMTI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RMTI revenue growth forecast

How is RMTI forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
-20.53%
Industry
4.04%
Market
143.45%
RMTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RMTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RMTI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
RMTI$1.15N/AN/A
SCYX$0.77N/AN/A
QNTM$14.44N/AN/A
CPIX$3.51N/AN/A
TLPH$1.14N/AN/A
View Top Pharmaceutical Stocks

Rockwell Medical Stock Forecast FAQ

What is RMTI's earnings growth forecast for 2025-2026?

(NASDAQ: RMTI) Rockwell Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 214.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 61.16%.

Rockwell Medical's earnings in 2025 is -$2,099,000.On average, 1 Wall Street analyst forecast RMTI's earnings for 2025 to be -$5,853,160, with the lowest RMTI earnings forecast at -$5,853,160, and the highest RMTI earnings forecast at -$5,853,160.

In 2026, RMTI is forecast to generate -$3,098,732 in earnings, with the lowest earnings forecast at -$3,098,732 and the highest earnings forecast at -$3,098,732.

If you're new to stock investing, here's how to buy Rockwell Medical stock.

What is RMTI's revenue growth forecast for 2025-2026?

(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of -20.53% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 143.45%.

Rockwell Medical's revenue in 2025 is $87,966,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2025 to be $2,407,025,908, with the lowest RMTI revenue forecast at $2,407,025,908, and the highest RMTI revenue forecast at $2,407,025,908.

In 2026, RMTI is forecast to generate $2,809,172,420 in revenue, with the lowest revenue forecast at $2,809,172,420 and the highest revenue forecast at $2,809,172,420.

What is RMTI's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: RMTI) forecast ROA is -5.89%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 10.11%.

What is RMTI's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: RMTI) Rockwell Medical's current Earnings Per Share (EPS) is -$0.08. On average, analysts forecast that RMTI's EPS will be -$0.17 for 2025, with the lowest EPS forecast at -$0.17, and the highest EPS forecast at -$0.17. In 2026, RMTI's EPS is forecast to hit -$0.09 (min: -$0.09, max: -$0.09).

What is RMTI's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: RMTI) forecast ROE is -10.19%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.